Table of Contents

February 2006; Volume 47,Issue 2

  1. Abi-dargham, Anissa

    1. Biodistribution and Radiation Dosimetry of the Dopamine D2 Ligand 11C-Raclopride Determined from Human Whole-Body PET
      Mark Slifstein, Dah-Ren Hwang, Diana Martinez, Jesper Ekelund, Yiyun Huang, Elizabeth Hackett, Anissa Abi-Dargham and Marc Laruelle
      Journal of Nuclear Medicine February 1, 2006, 47 (2) 313-319;

  2. Ahmadzadehfar, Hojjat

    1. Factors Predicting Tracer Uptake in Somatostatin Receptor and MIBG Scintigraphy of Metastatic Gastroenteropancreatic Neuroendocrine Tumors
      Samer Ezziddin, Timur Logvinski, Charlotte Yong-Hing, Hojjat Ahmadzadehfar, Hans-Peter Fischer, Holger Palmedo, Jan Bucerius, Michael J. Reinhardt and Hans-Jürgen Biersack
      Journal of Nuclear Medicine February 1, 2006, 47 (2) 223-233;

  3. Allen-auerbach, Martin

    1. Standard PET/CT of the Chest During Shallow Breathing Is Inadequate for Comprehensive Staging of Lung Cancer
      Martin Allen-Auerbach, Kristen Yeom, John Park, Michael Phelps and Johannes Czernin
      Journal of Nuclear Medicine February 1, 2006, 47 (2) 298-301;

  4. Anthony, Catherine T.

    1. In Vitro Modeling of the Clinical Interactions Between Octreotide and 111In-Pentetreotide: Is There Evidence of Somatostatin Receptor Downregulation?
      Susan H. Gunn, Joshua E. Schwimer, Mary Cox, Catherine T. Anthony, Mary Sue O'Dorisio and Eugene A. Woltering
      Journal of Nuclear Medicine February 1, 2006, 47 (2) 354-359;

  5. Baldini, Federica

    1. The Impact of Lymphoscintigraphy Technique on the Outcome of Sentinel Node Biopsy in 1,313 Patients with Cutaneous Melanoma: An Italian Multicentric Study (SOLISM–IMI)
      Carlo Riccardo Rossi, Gian Luca De Salvo, Giuseppe Trifirò, Simone Mocellin, Giorgio Landi, Giuseppe Macripò, Paolo Carcoforo, Giuseppe Ricotti, Giuseppe Giudice, Franco Picciotto, Davide Donner, Franco Di Filippo, Maria Cristina Montesco, Dario Casara, Mauro Schiavon, Mirto Foletto, Federica Baldini and Alessandro Testori
      Journal of Nuclear Medicine February 1, 2006, 47 (2) 234-241;

  6. Barbet, Jacques

    1. Targeting, Toxicity, and Efficacy of 2-Step, Pretargeted Radioimmunotherapy Using a Chimeric Bispecific Antibody and 131I-Labeled Bivalent Hapten in a Phase I Optimization Clinical Trial
      Françoise Kraeber-Bodéré, Caroline Rousseau, Caroline Bodet-Milin, Ludovic Ferrer, Alain Faivre-Chauvet, Loïc Campion, Jean-Philippe Vuillez, Anne Devillers, Chien-Hsing Chang, David M. Goldenberg, Jean-François Chatal and Jacques Barbet
      Journal of Nuclear Medicine February 1, 2006, 47 (2) 247-255;

  7. Barnes, N. Lynn

    1. The SNM Strategic Plan for Education
      Tom R. Miller, Alan H. Maurer and N. Lynn Barnes
      Journal of Nuclear Medicine February 1, 2006, 47 (2) 27N-28N;

  8. Bauer, Andreas

    1. 18F-CPFPX PET: On the Generation of Parametric Images and the Effect of Scan Duration
      Philipp T. Meyer, David Elmenhorst, Andreas Matusch, Oliver Winz, Karl Zilles and Andreas Bauer
      Journal of Nuclear Medicine February 1, 2006, 47 (2) 200-207;

  9. Bauer, Dagmar

    1. 18F-FET PET Compared with 18F-FDG PET and CT in Patients with Head and Neck Cancer
      Dirk Pauleit, Andre Zimmermann, Gabriele Stoffels, Dagmar Bauer, Jörn Risse, Michael O. Flüss, Kurt Hamacher, Heinz H. Coenen and Karl-Josef Langen
      Journal of Nuclear Medicine February 1, 2006, 47 (2) 256-261;

  10. Biersack, Hans-Jürgen

    1. Factors Predicting Tracer Uptake in Somatostatin Receptor and MIBG Scintigraphy of Metastatic Gastroenteropancreatic Neuroendocrine Tumors
      Samer Ezziddin, Timur Logvinski, Charlotte Yong-Hing, Hojjat Ahmadzadehfar, Hans-Peter Fischer, Holger Palmedo, Jan Bucerius, Michael J. Reinhardt and Hans-Jürgen Biersack
      Journal of Nuclear Medicine February 1, 2006, 47 (2) 223-233;
« Previous (Pages : 1 2 3 4 5 6 ... 20) Next »
Back to top

In this issue